Matching slides 303,780
Current window 209,971-210,000
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

209,971-210,000 of 303,780

filter-aware
05
The slide uses stacked bar charts for revenue composition and simple bar charts for session volume.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
06
The slide shows a positive trend in revenue growth and a reduction in Adjusted EBITA loss.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
07
The slide uses a dual-chart layout to compare revenue composition and profitability trends.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
08
The slide shows a decline in Consumer revenue while Payor and DTE revenue show consistent growth throughout 2022.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
09
The slide uses three distinct bar charts to illustrate cost reduction and EBITDA improvement trends.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
10
The slide uses a four-column layout to categorize strategic operational focus areas.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
11
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
12
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
13
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
14
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
15
Includes detailed footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
01
Slide 1
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
03
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
04
The slide uses a three-column layout to summarize corporate actions.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
05
The slide uses a three-column layout to categorize corporate objectives.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
07
The slide uses two bar charts to illustrate growth trends over five quarters.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Quick Win Big Bet1 hit
09
The slide outlines a clinical trial methodology using a timeline-based process flow.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
10
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
11
The slide uses a two-part structure: a top section for market sizing/segmentation and a bottom section for a competitive product comparison table.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
12
The chart is a forest plot showing LS Mean differences with 95% confidence intervals.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
13
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
14
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
15
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
18
The table displays projected royalties and milestones for 2023-2026. The slide highlights the transition of royalty payments back to Theravance Biopharma starting in 2029.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
20
Slide 20 of the presentation.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
21
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
22
Includes a footnote regarding market research methodology.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
23
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
24
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
25
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit